Alumis Inc. (ALMS): Share Repurchases
$17.0K
Year ended 2025-12-31
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.0K | +183.3% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $6.0K | -90.6% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $64.0K | n/a | 2025-03-19, From 2023-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Alumis Inc. (ALMS) | 2025-12-31 | $17.0K | +183.3% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $471.4K | -67.8% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $0 | -100.0% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $0 | -100.0% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $13.76M | n/a |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $263.5K | -54.5% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2024-12-31 | $1.73M | +110.0% |
| Nektar Therapeutics (NKTR) | 2025-12-31 | $0 | -100.0% |
| Roivant Sciences Ltd. (ROIV) | 2025-03-31 | $1.29B | n/a |
Compare ALMS, ETST, SBFM, LIFD side by side · Screen every company in Pharmaceutical Preparations ↗